Engineering lubrication in articular cartilage

Department of Orthopaedic Surgery, Lawrence Ellison Center for Tissue Regeneration and Repair, School of Medicine, University of California, Davis, Sacramento, California, USA.
Tissue Engineering Part B Reviews (Impact Factor: 4.64). 09/2011; 18(2):88-100. DOI: 10.1089/ten.TEB.2011.0394
Source: PubMed

ABSTRACT Despite continuous progress toward tissue engineering of functional articular cartilage, significant challenges still remain. Advances in morphogens, stem cells, and scaffolds have resulted in enhancement of the bulk mechanical properties of engineered constructs, but little attention has been paid to the surface mechanical properties. In the near future, engineered tissues will be able to withstand and support the physiological compressive and tensile forces in weight-bearing synovial joints such as the knee. However, there is an increasing realization that these tissue-engineered cartilage constructs will fail without the optimal frictional and wear properties present in native articular cartilage. These characteristics are critical to smooth, pain-free joint articulation and a long-lasting, durable cartilage surface. To achieve optimal tribological properties, engineered cartilage therapies will need to incorporate approaches and methods for functional lubrication. Steady progress in cartilage lubrication in native tissues has pushed the pendulum and warranted a shift in the articular cartilage tissue-engineering paradigm. Engineered tissues should be designed and developed to possess both tribological and mechanical properties mirroring natural cartilage. In this article, an overview of the biology and engineering of articular cartilage structure and cartilage lubrication will be presented. Salient progress in lubrication treatments such as tribosupplementation, pharmacological, and cell-based therapies will be covered. Finally, frictional assays such as the pin-on-disk tribometer will be addressed. Knowledge related to the elements of cartilage lubrication has progressed and, thus, an opportune moment is provided to leverage these advances at a critical step in the development of mechanically and tribologically robust, biomimetic tissue-engineered cartilage. This article is intended to serve as the first stepping stone toward future studies in functional tissue engineering of articular cartilage that begins to explore and incorporate methods of lubrication.

Download full-text


Available from: Kyriacos Athanasiou, Aug 09, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cartilage lesions of the knee, talus, ankle and hip generate chronic symptoms represented by pain associated to weight bearing, stiffness, locking and swelling of damaged joints that reduce the ability to walk, work and to carry out sports range of motion. Cartilage degeneration reduces the quality of life and has a huge impact on public health. Articular cartilage repair is a very hot topic for biomedical sciences and has evolving rapidly due to groundbreaking advances in tissue engineering driven by cell biology and biomaterials. The study here analyzes the publications and patents of cartilage tissue engineering to determine the patterns of the new therapies possibilities of cartilage repair to replace joint arthroplasties in the future. Findings, based on scientific and technological outputs, show that new clinical applications of Autologous Chondrocyte Implantation (ACI) and Chondrogenic Differentiation of Mesenchymal Stem Cells (MSCs) are fruitful approaches for cartilage regenerative medicine that should replace the artificial joint replacement in not-too-distant future. In fact, these new technological paradigms repair the cartilage with more efficacy and have been generating a revolution in clinical practice due to benefits in terms of higher quality of life.
    12/2012; 2(4). DOI:10.1007/s12553-012-0032-5
  • [Show abstract] [Hide abstract]
    ABSTRACT: Current therapies for articular cartilage defects often result in fibrocartilaginous tissue. To achieve regeneration with hyaline articular cartilage, tissue-engineering approaches employing cell-seeded scaffolds have been investigated. However, limitations of scaffolds include phenotypic alteration of cells, stress-shielding, hindrance of neotissue organization, and degradation product toxicity. This study employs a self-assembling process to produce tissue-engineered constructs over agarose in vitro without using a scaffold. Compared to past studies using various meshes and gels as scaffolding materials, the self-assembly method yielded constructs with comparable GAG and collagen content. By 12 weeks, the self-assembling process resulted in tissue-engineered constructs that were hyaline- like in appearance with histological, biochemical, and biomechanical properties approaching those of native articular cartilage. Overall, constructs contained two thirds more GAG per dry weight than calf articular cartilage. Collagen per dry weight reached more than one third the level of native tissue. IHC and gel electrophoresis showed collagen type II production and absence of collagen type I. More importantly, self-assembled constructs reached well over one third the stiffness of native tissue.
    Tissue Engineering 05/2006; 12(4):969-79. DOI:10.1089/ten.2006.12.969 · 4.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chondrocyte is a unique cell type in articular cartilage tissue and is essential for cartilage formation and functionality. It arises from mesenchymal stem cells (MSCs) and is regulated by a series of cytokine and transcription factor interactions, including the transforming growth factor-beta super family, fibroblast growth factors, and insulin-like growth factor-1. To understand the biomechanisms of the chondrocyte differentiation process, various cellular model systems have been employed, such as primary chondrocyte culture, clonal normal cell lines (HCS-2/8, Ch-1, ATDC5, CFK-2, and RCJ3.1C5.18), and transformed clonal cell lines (T/C-28a2, T/C-28a4, C-28/I2, tsT/AC62, and HPV-16 E6/E7). Additionally, cell culture methods, including conventional monolayer culture, three-dimensional scaffold culture, bioreactor culture, pellet culture, and organ culture, have been established to create stable environments for the expansion, phenotypic maintenance, and subsequent biological study of chondrocytes for clinical application. Knowledge gained through these study systems has allowed for the use of chondrocytes in orthopedics for the treatment of cartilage injury and epiphyseal growth plate defects using tissue-engineering approaches. Furthermore, the potential of chondrocyte implantation for facial reconstruction, the treatment of long segmental tracheal defects, and urinary incontinence and vesicoureteral reflux are being investigated. This review summarizes the present study of chondrocyte biology and the potential uses of this cell in orthopedics and other disciplines.
    Tissue Engineering 08/2006; 12(7):1971-84. DOI:10.1089/ten.2006.12.1971 · 4.25 Impact Factor
Show more